Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2008 052 147.8 |
96 | EP file number | EAKZ | 12 19 8754.9 |
97 | EP publication number | EPN | 2574677 |
54 | Designation/title | TI | Zellkulturverfahren |
51 | IPC main class | ICM (ICMV) | C12P 21/02 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | C12N 9/64 (2006.01) |
22 | DE application date | DAT | Dec 22, 2008 |
96 | EP application date | EAT | Dec 22, 2008 |
43 | Date of first publication | OT | Apr 3, 2013 |
| Date of publication of grant | PET | Sep 13, 2017 |
71/73 | Applicant/owner | INH | Takeda Pharmaceutical Company Limited, Osaka-shi, Osaka, JP |
72 | Inventor | IN | Giovagnoli, Andre, 25130 Villers-le-lac, FR; Roy, Sylvain, Santa Monica, CA 90403, US; Ducros, Veronique, 1424 Champagne, CH; Charlot, Virginie, 2300 La Chaux-de-fonds, CH; Stauffer, Yves-Olivier, 1066 Epalinges, CH |
74 | Representative | VTR | Hoffmann Eitle Patent- und Rechtsanwälte PartmbB, 81925 München, DE |
| Address for service | | HOFFMANN - EITLE Patent- und Rechtsanwälte PartmbB, 81925 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 9328 P Dec 27, 2007
|
| Due date | FT FG | Dec 31, 2024 Annual fee for the 17th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000002574677 Searchable text:
EP000002574677 Original document:
EP000002574677B1 Searchable text:
EP000002574677B1 |
43 | Date of first publication | EVT | Apr 3, 2013 |
| Date of the first transfer into DPMAregister | EREGT | May 17, 2013 |
| Date of the (most recent) update in DPMAregister | REGT | Apr 17, 2025 (Show all update days)(Hide all update days)- Apr 17, 2025
- Procedures: Procedure relating to EP application, EPO publication of mention of grant , 13.09.2017: new
- Procedures: Procedure relating to EP application, EPO publication of mention of grant , 13.09.2017: deleted
- Nov 12, 2024
- May 17, 2013
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 7)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Jun 4, 2021 |
| Issue number | HN | 28 |
| Year | PJ | 2021 |
| Publication date | VT | Jul 15, 2021 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | Takeda Pharmaceutical Co. Ltd., Osaka, JP |
71/73 | Previous applicant/owner | INHF | Baxalta GmbH, Glattpark, Opfikon, CH, Baxalta Inc., Bannockburn, Ill., US |
| Date of update of the procedure | REGT | Jul 15, 2021 |